Brain dopamine metabolism in patients with Parkinson's disease measured with positron emission tomography.
AUTOR(ES)
Leenders, K L
RESUMO
L-[18F] fluorodopa was administered in trace amounts intravenously to healthy control subjects and to patients with Parkinson's disease. Striatal uptake of radioactivity was measured using positron emission tomography. The capacity of the striatum to retain tracer was severely impaired in patients compared to controls. This may reflect a reduction of striatal dopamine storage in Parkinson's disease. Patients showing the "on/off" phenomenon had an even greater decrease of striatal storage capacity.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1028944Documentos Relacionados
- Dopamine D1 receptors in Parkinson's disease and striatonigral degeneration: a positron emission tomography study.
- Regional structure-function correlations in chronic obstructive lung disease measured with positron emission tomography.
- Cerebral responses to pain in patients with atypical facial pain measured by positron emission tomography.
- Mapping memory with positron emission tomography.
- The nigrostriatal dopaminergic pathway in Wilson's disease studied with positron emission tomography.
